Papatheodoridis GV - Search Results

1

Jeng WJ, Papatheodoridis GV, Lok ASF. Jeng WJ, et al. Among authors: papatheodoridis gv. Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9. Lancet. 2023. PMID: 36774930 Review.

2

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ. Papatheodoridis GV, et al. Lancet Infect Dis. 2008 Mar;8(3):167-78. doi: 10.1016/S1473-3099(07)70264-5. Epub 2007 Nov 28. Lancet Infect Dis. 2008. PMID: 18053766 Review.

3

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Papatheodoridis GV, et al. J Hepatol. 2010 Aug;53(2):348-56. doi: 10.1016/j.jhep.2010.02.035. Epub 2010 Apr 27. J Hepatol. 2010. PMID: 20483498 Free article. Review.

4

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, Colombo M, Delarocque-Astagneau E, Dusheiko G, Esmat G, Esteban R, Goldberg D, Gore C, Lok AS, Manns M, Marcellin P, Papatheodoridis G, Peterle A, Prati D, Piorkowsky N, Rizzetto M, Roudot-Thoraval F, Soriano V, Thomas HC, Thursz M, Valla D, van Damme P, Veldhuijzen IK, Wedemeyer H, Wiessing L, Zanetti AR, Janssen HL. Hatzakis A, et al. J Viral Hepat. 2011 Sep;18 Suppl 1:1-16. doi: 10.1111/j.1365-2893.2011.01499.x. J Viral Hepat. 2011. PMID: 21824223 Free article.

5

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

European Association For The Study Of The Liver. European Association For The Study Of The Liver. J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20. J Hepatol. 2012. PMID: 22436845 Free article. No abstract available.

6

Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.

Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A. Papatheodoridis GV, et al. J Hepatol. 2012 Jul;57(1):196-202. doi: 10.1016/j.jhep.2011.11.030. Epub 2012 Mar 23. J Hepatol. 2012. PMID: 22450396 Free article. Review.

7

HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

Vlachogiannakos J, Papatheodoridis GV. Vlachogiannakos J, et al. Among authors: papatheodoridis gv. Liver Int. 2014 Feb;34 Suppl 1:127-32. doi: 10.1111/liv.12404. Liver Int. 2014. PMID: 24373089 Review.

8

Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.

Papatheodoridis GV, Tsochatzis E, Hardtke S, Wedemeyer H. Papatheodoridis GV, et al. Liver Int. 2014 Nov;34(10):1452-63. doi: 10.1111/liv.12565. Epub 2014 May 16. Liver Int. 2014. PMID: 24750532 Review.

9

Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.

Papatheodoridis G, Sypsa V, Kantzanou M, Nikolakopoulos I, Hatzakis A. Papatheodoridis G, et al. J Viral Hepat. 2015 Apr;22(4):409-15. doi: 10.1111/jvh.12314. Epub 2014 Sep 11. J Viral Hepat. 2015. PMID: 25209157

10

Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?

Vlachogiannakos J, Papatheodoridis GV. Vlachogiannakos J, et al. Among authors: papatheodoridis gv. Liver Int. 2015 Jan;35 Suppl 1:100-6. doi: 10.1111/liv.12719. Liver Int. 2015. PMID: 25529094 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page